Nursing Management of Cancer Treatment-Induced Cardiotoxicity

STATEMENT OF NEED

Several studies reveal that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. Adverse cardiac effects may occur immediately after cessation of therapy or, in some cases, years after the therapy has been discontinued. Often the cardiotoxicity presents in subtle ways, and a lack of awareness results in high morbidity and mortality. It is important for oncology nurses to be aware of current advances in the management of treatment-induced cardiotoxicity as this complication limits long-term survival.

TARGET AUDIENCE

Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of patients with cancer.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

1. Discuss the cancer therapies associated with cardiotoxicity
2. Explain the methods to screen for cancer treatment-induced cardiotoxicity
3. Describe measures to protect against cancer treatment-induced cardiotoxicity